Spire Corp....ein sicherer Gewinner - 500 Beiträge pro Seite
eröffnet am 07.11.00 09:33:52 von
neuester Beitrag 22.11.00 09:23:11 von
neuester Beitrag 22.11.00 09:23:11 von
Beiträge: 11
ID: 292.496
ID: 292.496
Aufrufe heute: 0
Gesamt: 859
Gesamt: 859
Aktive User: 0
ISIN: US8485651074 · WKN: 870534
0,0100
EUR
0,00 %
0,0000 EUR
Letzter Kurs 11.04.17 Stuttgart
Werte aus der Branche Elektrogeräte
Wertpapier | Kurs | Perf. % |
---|---|---|
1,1400 | +1.040,00 | |
36,57 | +400,92 | |
6,0000 | +272,67 | |
1,1900 | +91,94 | |
16,900 | +45,19 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,8700 | -10,10 | |
0,5800 | -10,77 | |
2,2200 | -12,25 | |
35,96 | -16,51 | |
93,68 | -51,34 |
WKN: 870534 (BER/FRA)
Macht in Solarzellen und Biomech./tech.
Die Bio-Group soll ausgegliedert werden, dazu gibt es noch eine Stock-Divident von 1 neuen Aktie pro am 22. Dec. gehaltener Aktie.
Die Company ist gerade mal mit 45 Mio.$ bewertet. Bis zum 22. wird niemand auch nur ein Stück aus der Hand geben.
Die Aktei ist zum Steigen verdammt
Press Release
Spire Corporation Announces: Spire Biomedical Inc. Formed As A Separate Corporation And Declares Stock Dividend
Spire Corporation To Focus On Solar Energy
INTERNET WIRE -- Spire Corporation (NASDAQ: SPIR - news), which provides products and services to solar energy and biomedical device markets worldwide, announced today that it has formed a wholly-owned subsidiary, "Spire Biomedical Inc.", and declared a dividend in the form of one share of Spire Corporation common stock for each outstanding share for stockholders of record on November 22, 2000 to be distributed on December 22, 2000.
Steps Taken as Part of Continuing Plan
Roger G. Little, President and Chairman of Spire Corporation, said, "The incorporation of Spire Biomedical Inc. is part of our continuing plan to focus Spire Corporation on becoming a pure play in the solar energy industry. This restructuring effort began when we sold the assets of our telecommunications business late last year. Separating Spire into two autonomous, market-driven entities to increase the value of our Corporation has long been a goal. With its own identity, Spire Biomedical Inc. can more easily pursue its own strategic relationships in the biomedical device industry and acquire its own capital."
Spire Corporation to Focus on Solar Energy
"Spire Corporation is the world`s leading supplier of the tools to manufacture photovoltaic (PV) modules. For more than twenty years, Spire has been supplying module manufacturing equipment and related technology worldwide, establishing strong relationships with more than 100 customers. Now, the PV industry is expanding rapidly due to the demand for wireless power for telecommunications and opportunities created by electric utility deregulation."
"Spire Corporation will further capitalize on this growing market by concentrating its energy and resources on leveraging its technology, PV business development know-how and worldwide customer relationships to provide new equipment, production lines, and solar energy businesses. Spire is investing in marketing and product development to aggressively pursue its Solar Brightfield(TM) strategy."
"Spire is offering turnkey PV module factories to the electric power industry to address new opportunities created by the need for reliable premium power, electric utility deregulation, the demand for clean energy, and the desire to revitalize utility owned brownfields. The first of these factories, Spire Solar Chicago, will produce the world`s largest PV array to convert an environmental brownfield into a Solar Brightfield(TM) with ComEd, the local utility, and the City of Chicago as partners."
Spire Biomedical Inc. Positioned for Independence
"For more than 15 years, Spire Biomedical has been a world leader in providing surface treatment services to the medical device industry to improve the performance of implantable devices. Spurred by the aging population, demand for Spire Biomedical IonGuard® branded orthopedic surface treatments is increasing."
"Spire Biomedical is investing in product development targeting growth segments of the orthopedic device market by offering surface treatments for bone integration of prosthetic devices and, eventually, coatings for tissue growth. Spire Biomedical is also moving toward vertical integration into medical devices by introducing surface engineered renal care catheters. The incorporation of Spire Biomedical will permit it to more rapidly exploit the opportunities before it."
Stock Dividend
Mr. Little went on to say, "In addition to creating Spire Biomedical Inc. as a separate corporation, Spire Corporation`s Board of Directors has declared a stock dividend for stockholders of record on November 22, 2000 to be paid on December 22, 2000. The stock dividend will consist of one share of Spire common stock for every outstanding share. Included in the stock dividend pool will be 552,160 shares of Spire Corporation treasury stock."
"Increasing Spire`s stock float will improve its liquidity making it easier for institutions and individual investors to purchase Spire stock, broadening ownership in the Company. Creating more shares will also give Spire added flexibility in possible future business actions such as acquisitions."
"These restructuring steps have been taken as part of our continuing plan to increase stockholder value by giving the Corporation the opportunity and flexibility to grow by exploiting its unique solar and biomedical technologies, their market positions, capital resources, and the operations that we took years to build."
Spire Corporation
Spire Corporation is the world`s largest supplier of photovoltaic module manufacturing equipment, turnkey production lines, and solar energy businesses with equipment in 144 customer facilities in 39 countries worldwide. Through its subsidiary, Spire Biomedical Inc., Spire Corporation is a leader in providing surface engineering treatments to orthopedic and other implantable medical devices to improve their performance in the body.
Certain matters discussed in this News Release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on government agencies and other third parties for funding contract research and services, as well as other factors described in the Company`s Form 10-KSB filed with the Securities and Exchange Commission.
Visit our web site at www.spirecorp.com
Macht in Solarzellen und Biomech./tech.
Die Bio-Group soll ausgegliedert werden, dazu gibt es noch eine Stock-Divident von 1 neuen Aktie pro am 22. Dec. gehaltener Aktie.
Die Company ist gerade mal mit 45 Mio.$ bewertet. Bis zum 22. wird niemand auch nur ein Stück aus der Hand geben.
Die Aktei ist zum Steigen verdammt
Press Release
Spire Corporation Announces: Spire Biomedical Inc. Formed As A Separate Corporation And Declares Stock Dividend
Spire Corporation To Focus On Solar Energy
INTERNET WIRE -- Spire Corporation (NASDAQ: SPIR - news), which provides products and services to solar energy and biomedical device markets worldwide, announced today that it has formed a wholly-owned subsidiary, "Spire Biomedical Inc.", and declared a dividend in the form of one share of Spire Corporation common stock for each outstanding share for stockholders of record on November 22, 2000 to be distributed on December 22, 2000.
Steps Taken as Part of Continuing Plan
Roger G. Little, President and Chairman of Spire Corporation, said, "The incorporation of Spire Biomedical Inc. is part of our continuing plan to focus Spire Corporation on becoming a pure play in the solar energy industry. This restructuring effort began when we sold the assets of our telecommunications business late last year. Separating Spire into two autonomous, market-driven entities to increase the value of our Corporation has long been a goal. With its own identity, Spire Biomedical Inc. can more easily pursue its own strategic relationships in the biomedical device industry and acquire its own capital."
Spire Corporation to Focus on Solar Energy
"Spire Corporation is the world`s leading supplier of the tools to manufacture photovoltaic (PV) modules. For more than twenty years, Spire has been supplying module manufacturing equipment and related technology worldwide, establishing strong relationships with more than 100 customers. Now, the PV industry is expanding rapidly due to the demand for wireless power for telecommunications and opportunities created by electric utility deregulation."
"Spire Corporation will further capitalize on this growing market by concentrating its energy and resources on leveraging its technology, PV business development know-how and worldwide customer relationships to provide new equipment, production lines, and solar energy businesses. Spire is investing in marketing and product development to aggressively pursue its Solar Brightfield(TM) strategy."
"Spire is offering turnkey PV module factories to the electric power industry to address new opportunities created by the need for reliable premium power, electric utility deregulation, the demand for clean energy, and the desire to revitalize utility owned brownfields. The first of these factories, Spire Solar Chicago, will produce the world`s largest PV array to convert an environmental brownfield into a Solar Brightfield(TM) with ComEd, the local utility, and the City of Chicago as partners."
Spire Biomedical Inc. Positioned for Independence
"For more than 15 years, Spire Biomedical has been a world leader in providing surface treatment services to the medical device industry to improve the performance of implantable devices. Spurred by the aging population, demand for Spire Biomedical IonGuard® branded orthopedic surface treatments is increasing."
"Spire Biomedical is investing in product development targeting growth segments of the orthopedic device market by offering surface treatments for bone integration of prosthetic devices and, eventually, coatings for tissue growth. Spire Biomedical is also moving toward vertical integration into medical devices by introducing surface engineered renal care catheters. The incorporation of Spire Biomedical will permit it to more rapidly exploit the opportunities before it."
Stock Dividend
Mr. Little went on to say, "In addition to creating Spire Biomedical Inc. as a separate corporation, Spire Corporation`s Board of Directors has declared a stock dividend for stockholders of record on November 22, 2000 to be paid on December 22, 2000. The stock dividend will consist of one share of Spire common stock for every outstanding share. Included in the stock dividend pool will be 552,160 shares of Spire Corporation treasury stock."
"Increasing Spire`s stock float will improve its liquidity making it easier for institutions and individual investors to purchase Spire stock, broadening ownership in the Company. Creating more shares will also give Spire added flexibility in possible future business actions such as acquisitions."
"These restructuring steps have been taken as part of our continuing plan to increase stockholder value by giving the Corporation the opportunity and flexibility to grow by exploiting its unique solar and biomedical technologies, their market positions, capital resources, and the operations that we took years to build."
Spire Corporation
Spire Corporation is the world`s largest supplier of photovoltaic module manufacturing equipment, turnkey production lines, and solar energy businesses with equipment in 144 customer facilities in 39 countries worldwide. Through its subsidiary, Spire Biomedical Inc., Spire Corporation is a leader in providing surface engineering treatments to orthopedic and other implantable medical devices to improve their performance in the body.
Certain matters discussed in this News Release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on government agencies and other third parties for funding contract research and services, as well as other factors described in the Company`s Form 10-KSB filed with the Securities and Exchange Commission.
Visit our web site at www.spirecorp.com
Gestern die Gewinne vom Vortag (12%) gehalten. Heute wird es weiter nach oben gehen. Die Shorties trauen sich nicht an so einen kleinen Wert...
Und wieder 6% im Plus bei einer Nasdaq die 7% abgibt.
Denke das Baby läuft bis zu 50€ min. bis Jahresende. Absolut unentdeckt und ein KGV von 9. Das in Verbindung mit Solar/Biotech ist schon fast unglaublich.
Denke das Baby läuft bis zu 50€ min. bis Jahresende. Absolut unentdeckt und ein KGV von 9. Das in Verbindung mit Solar/Biotech ist schon fast unglaublich.
Etwas zurückgetaxt auf 15,2$, allerdings bei geringsten Umsätzen und schlechter Nasdaq. Sobald die Nas gut läuft kommt der nächste Ausbruch. Ein neues ATH wurde heute schon markiert bei 16,5$.
Gnadenlos runtergetaxt worden durch den Market Maker um 9% am Freitag. Das geht aber nur kurze Zeit :-).
Das momentan sind Spitzeneinstiegskurse kurz vor dem Split.
Von einem US Kollegen:
" You will get a share of Spir for every share you own! This is a great deal and you would be crazy to sell before then. The MM
will rattle the cage to shake you out but IMO the real rise will come after the split. Institutions have wanted to get in but are
restricted to buy stocks with low floats and low prices. This solves the problem and we will still have a nice low float. Also Spir
is valued way too low compared to these recent ipo alternative energy companies with little revenue and no profits. My advice
is hang in there and buy on any and all dips."
Gruß
BL
Das momentan sind Spitzeneinstiegskurse kurz vor dem Split.
Von einem US Kollegen:
" You will get a share of Spir for every share you own! This is a great deal and you would be crazy to sell before then. The MM
will rattle the cage to shake you out but IMO the real rise will come after the split. Institutions have wanted to get in but are
restricted to buy stocks with low floats and low prices. This solves the problem and we will still have a nice low float. Also Spir
is valued way too low compared to these recent ipo alternative energy companies with little revenue and no profits. My advice
is hang in there and buy on any and all dips."
Gruß
BL
Comdirect sagt dazu:
ganz normaler 1-zu-1-Split!
Wird doch langsam Zeit, dass die Firma sich offiziell dazu äussert!!
In den amerikanischen Boards herrscht auch Unsicherheit.
Gruss,
jen
ganz normaler 1-zu-1-Split!
Wird doch langsam Zeit, dass die Firma sich offiziell dazu äussert!!
In den amerikanischen Boards herrscht auch Unsicherheit.
Gruss,
jen
Die Sache ist die: Am 22.11 gibt die Dividende...am 22.12 wird eingebucht.
Sollte der Kurs am 23.11 der gleiche wie heute sein =100%.
Der Market Maker hat den Kurs auf mieseste Art runtergetaxt. Wahrscheinlich selbst eingesammelt.
Sollte der Kurs am 23.11 der gleiche wie heute sein =100%.
Der Market Maker hat den Kurs auf mieseste Art runtergetaxt. Wahrscheinlich selbst eingesammelt.
hoffe dass wenigsten die 100% drinliegen. Habe sie für 6$ gekauft jedoch gehalten mit
Aussicht auf die Stockdiv. Schaueme halt mal. Wer ist denn dieser Market Maker. Teach me
Danke :-(
Aussicht auf die Stockdiv. Schaueme halt mal. Wer ist denn dieser Market Maker. Teach me
Danke :-(
Der MarketMaker ist derjenige der den Kurs feststellt, bzw. dafür verantwortlich ist.
Er kann in den USA wie auch hier auf eigene Rechnung kaufen. MM kennen ihre betreuten Aktien und deren Verhalten oft sehr genau.
Gruß
BL
Er kann in den USA wie auch hier auf eigene Rechnung kaufen. MM kennen ihre betreuten Aktien und deren Verhalten oft sehr genau.
Gruß
BL
Zur Klärung der Sachlage:
The stock dividend will be distributed on 12/22/00, to all shareholders of
record on 11/22/00 regardless as to whether they still retain the stock on
12/22/00. What adjustment to the price, if any, is up to the Market to
decide once the distribution is made.
Richard S. Gregorio
VP & CFO
Spire Corporation
One Patriots Park
Bedford, MA 01730-2396
Tel: (781) 275-6000
Fax: (781) 275-7470
mailto:rgregorio@spirecorp.com
http://www.spirecorp.com
The stock dividend will be distributed on 12/22/00, to all shareholders of
record on 11/22/00 regardless as to whether they still retain the stock on
12/22/00. What adjustment to the price, if any, is up to the Market to
decide once the distribution is made.
Richard S. Gregorio
VP & CFO
Spire Corporation
One Patriots Park
Bedford, MA 01730-2396
Tel: (781) 275-6000
Fax: (781) 275-7470
mailto:rgregorio@spirecorp.com
http://www.spirecorp.com
+22% gestern an der Nasdaq
Heute wahrscheinlich gleich Eröffnung bei 12 oder 13$...
Heute wahrscheinlich gleich Eröffnung bei 12 oder 13$...
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
-0,87 | |
0,00 | |
0,00 | |
-25,53 | |
+0,95 | |
-0,07 | |
+3,45 | |
+2,16 | |
0,00 | |
-21,33 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
97 | ||
51 | ||
35 | ||
35 | ||
28 | ||
27 | ||
24 | ||
24 | ||
20 | ||
19 |